Related Experiment Video
Updated: May 11, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Clinical risk stratification schemes to predict thromboembolism in patients with atrial fibrillation]
Tadakazu Hirai1, Hiroshi Inoue
1The Second Department of Internal Medicine, University of Toyama.
Insights
The CHA2DS2-VASc score improves stroke risk prediction in atrial fibrillation patients compared to the CHADS2 score. It helps identify truly low-risk individuals who may not require antithrombotic therapy.
Area of Science:
- Cardiology
- Neurology
- Public Health
Context:
- Atrial fibrillation (AF) significantly increases stroke risk.
- Current stroke risk stratification in AF patients has limitations, particularly for low-to-intermediate risk groups.
- The CHADS2 score is widely used but has suboptimal predictive accuracy.
Purpose:
- To evaluate the CHA2DS2-VASc score for improved ischemic stroke risk prediction in atrial fibrillation.
- To compare the performance of CHA2DS2-VASc with the CHADS2 score.
- To identify patients at truly low risk of stroke who might not need antithrombotic treatment.
Summary:
- The CHA2DS2-VASc score incorporates additional risk factors beyond the CHADS2 score.
- This enhanced score demonstrates superior predictive value for ischemic stroke in atrial fibrillation.
- It effectively identifies a subset of patients with a "truly low risk" of stroke.
Impact:
- Improved clinical decision-making for thromboprophylaxis in atrial fibrillation patients.
- Potential reduction in unnecessary antithrombotic treatment and associated bleeding risks.
- Enhanced patient management strategies for stroke prevention in the AF population.
Abstract:
Stroke is a serious complication associated with atrial fibrillation, but the risk can vary with clinical characteristics of individual patients. CHADS2 score is the most commonly used stratification scheme because of its simplicity. However, the predictive value for ischemic stroke has been limited in patients at "low and intermediate risk". CHA2DS2-VASc score, which extends CHADS2 scheme by considering additional stroke risk factors, has been recommended to identify "truly low risk" patients who may not need any antithrombotic treatment. This new scheme could improve decision-making for thromboprophylaxis in patients with atrial fibrillation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

